Impact of gut microbiota on acute kidney injury

doi:10.3877/cma.j.issn.2095-3216.2022.03.006

Abstract

Abstract:

Acute kidney injury (AKI) is a global health problem. Some evidence suggests that the gut microbiota plays a very important role in AKI. In animals, there is a reciprocal relationship between the host AKI and the gut microbiota. The gut microbiota can significantly affect the prognosis of AKI, and AKI can also lead to changes of the gut microbiota. The interaction between them is called the "gut-kidney" axis. This article reviewed the role of gut microbiota in AKI, the potential molecular mechanism of gut microbiota affecting AKI, and the application prospect of gut microbiota in AKI treatment.

Key words: Gut microbiota, Acute kidney injury, Short-chain fatty acids, Probiotics

Lijun Zhu, Xi Qiao. Impact of gut microbiota on acute kidney injury[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2022, 11(03): 148-151.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2022.03.006

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2022/V11/I03/148

Figures/Tables 1

References 30

[20]	Lee TH, Park D, Kim YJ, et al. Lactobacillus salivarius BP121 prevents cisplatin-induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p-cresol sulfate via alleviating dysbiosis [J]. Int J Mol Med, 2020, 45(4): 1130-1140.
[21]	Fernandes SM, Watanabe M, Vattimo MFF. Inflammation: improving understanding to prevent or ameliorate kidney diseases [J]. J Venom Anim Toxins Incl Trop Dis, 2021, 27：e20200162.
[22]	Karbach SH, Schönfelder T, Brandão I, et al. Gut microbiota promote angiotensin II-induced arterial hypertension and vascular dysfunction [J]. J Am Heart Assoc, 2016, 5(9): e003698.
[23]	Hu J, Luo H, Wang J, et al. Enteric dysbiosis-linked gut barrier disruption triggers early renal injury induced by chronic high salt feeding in mice [J]. Exp Mol Med, 2017, 49(8): e370.
[24]	Al-Harbi NO, Nadeem A, Ahmad SF, et al. Short chain fatty acid, acetate ameliorates sepsis-induced acute kidney injury by inhibition of NADPH oxidase signaling in T cells [J]. Int Immunopharmacol, 2018, 58: 24-31.
[25]	Zheng DW, Pan P, Chen KW, et al. An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure [J]. Nat Biomed Eng, 2020, 4(9): 853-862.
[26]	Suez J, Zmora N, Segal E, et al. The pros, cons, and many unknowns of probiotics [J]. Nat Med, 2019, 25(5): 716-729.
[27]	Wu H, Singer J, Kwan TK, et al. Gut microbial metabolites induce donor-specific tolerance of kidney allografts through induction of T regulatory cells by short-chain fatty acids [J]. J Am Soc Nephrol, 2020, 31(7): 1445-1461.
[28]	Dong T, Aronsohn A, Gautham Reddy K, et al. Rifaximin decreases the incidence and severity of acute kidney injury and hepatorenal syndrome in cirrhosis [J]. Dig Dis Sci, 2016, 61(12): 3621-3626.
[29]	Christian FK, Hans-Joachim P, Sonja K, et al. Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney [J]. Immunity, 2016, 45(5): 1078-1092.
[30]	Nirula A, Nilsen J, Klekotka P, et al. Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases [J]. Rheumatology, 2016, 55(Suppl 2): ii43-ii55.
[1]	宫铭，陈香美. 急性肾损伤后脑损伤的研究进展[J/CD]. 中华肾病研究电子杂志，2021, 10(1): 40-43.
[2]	Lee SA, Cozzi M, Bush EL, et al. Distant organ dysfunction in acute kidney injury: a review [J]. Am J Kidney Dis, 2018, 72(6): 846-856.
[3]	李江涛，刘怡果，王立瑞，等. 肠道菌群与缺血性急性肾损伤的交互作用[J]. 中华肾脏病杂志，2019, 35(11): 871-875.
[4]	Liu L, Li Q, Yang Y, et al. Biological function of short-chain fatty acids and its regulation on intestinal health of poultry [J]. Front Vet Sci, 2021, 8: 736739.
[5]	秦昊，张健，林俊. 肠道菌群与肾移植的研究进展[J]. 器官移植，2020, 11(4): 516-520, 532.
[6]	Kobayashi T, Iwata Y, Nakade Y, et al. Significance of the gut microbiota in acute kidney injury [J]. Toxins, 2021, 13(6): 369.
[7]	Jang HR, Gandolfo MT, Ko GJ, et al. Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury [J]. Am J Physiol Renal Physiol, 2009, 297(5): F1457-F1465.
[8]	Al Khodor S, Shatat IF. Gut microbiome and kidney disease: a bidirectional relationship [J]. Pediatr Nephrol, 2017, 32(6): 921-931.
[9]	Gong J, Noel S, Pluznick JL, et al. Gut microbiota-kidney cross-talk in acute kidney injury [J]. Semin Nephrol, 2019, 39(1): 107-116.
[10]	Liu Y, Li YJ, Loh YW, et al. Fiber derived microbial metabolites prevent acute kidney injury through G-protein coupled receptors and HDAC inhibition [J]. Front Cell Dev Biol, 2021, 9: 648-639.
[11]	胡守慈，马红珍. 肠-肾串话机制在急性肾损伤中的研究进展[J]. 临床肾脏病杂志，2021, 21(7): 608-613.
[12]	Andrade-Oliveira V, Amano MT, Correa-Costa M, et al. Gut bacteria products prevent AKI induced by ischemia-reperfusion [J]. J Am Soc Nephrol, 2015, 26(8): 1877-1888.
[13]	Felizardo R, de Almeida DC, Pereira RL, et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms [J]. FASEB J, 2019, 33(11): 11894-11908.
[14]	Hsu CN, Hou CY, Lee CT, et al. The interplay between maternal and post-weaning high-fat diet and gut microbiota in the developmental programming of hypertension [J]. Nutrients, 2019, 11(9): 1982.
[15]	Yanda MK, Liu Q, Cebotaru V, et al. Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca²⁺ in knock-out mouse models of polycystic kidney disease [J]. J Biol Chem, 2017, 292(43): 17897-17908.
[16]	Obeid R, Awwad HM, Rabagny Y, et al. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism [J]. Am J Clin Nutr, 2016, 103(3): 703-711.
[17]	Nakade Y, Iwata Y, Furuichi K, et al. Gut microbiota-derived D-serine protects against acute kidney injury [J]. JCI Insight, 2018, 3(20): e97957.
[18]	Tang WHW, Wang Z, Kennedy DJ, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease [J]. Circ Res, 2015, 116(3): 448-455.
[19]	Tomlinson JAP, Wheeler DC. The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease [J]. Kidney Int, 2017, 92(4): 809-815.

Please choose a citation manager

Content to export